FAS and cancer: Upon interaction with cancer cells, γδ T cells can express Fas ligand (FASL) and TNF-related apoptosis-inducing ligand (TRAIL), which, upon binding to their respective receptors, Fas (CD95) and TRAIL-R1/R2, activate death pathways in target cells (179, 180).